Nevertheless, a recent study by Mamiya et al. reported that a decreased expression of TGF-β receptor type II was associated with intrahepatic metastasis, in accordance with the controversial role of TGF-β in HCC [105]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.